FRAXA Research Foundation: Clinical Trial Grants

FRAXA invites investigator-initiated research applications for innovative pilot studies aimed at developing and characterising new therapeutic approaches for the treatment and ultimate cure of fragile X syndrome.

The highest priority is given to clinical trials of potentially disease-modifying therapeutics which have previously been validated in fragile X animal models.

Funding & Duration

Grants are flexible in amount and duration. Applications are ranked based on relative value, so smaller requests have an advantage.


Must involve human subjects with fragile X.

Available to researchers internationally.

Submission Requirements

Further Information

Need Help?

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Ongoing Opportunities. Bookmark the permalink.

Comments are closed.